ABU DHABI, 29th June, 2026 (WAM) -- M42's Insights Research Organisation and Solutions (IROS), in collaboration with the Department of Health - Abu Dhabi (DoH) and Halia Therapeutics, a US-based clinical-stage biotechnology company, has launched the UAE's first genomics-driven clinical trial, marking a major step in translating the Emirati Genome Programme (EGP) into real-world clinical application. Alzheimer's d